{"id":261989,"date":"2026-09-22T13:21:54","date_gmt":"2026-09-22T07:51:54","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=261989"},"modified":"2026-09-22T13:21:54","modified_gmt":"2026-09-22T07:51:54","slug":"why-rubicon-research-share-price-price-fall-2026-09-22","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-rubicon-research-share-price-price-fall-2026-09-22\/","title":{"rendered":"RUBICON RESEARCH (RUBICON) Share Price falls 2.25% as stock closes lower today"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/rubicon\/rubicon-research-limited-share-price-today\">RUBICON RESEARCH (RUBICON)<\/a> share price fell to Rs 1,692.3 today, down 2.25% from the previous close. Market cap was Rs 29,030.99 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong>&nbsp;&nbsp;&nbsp;22 September 2026 at 1:19:06 PM IST<\/p>\n<p style=\"margin-top:0!important;\">Rubicon Research Share Price fell to Rs 1,692.30 today, down 2.25% from the previous close, while the company\u2019s market capitalisation stood at Rs 29,030.99 crore. The move places Rubicon Research in the spotlight for investors tracking Rubicon Research Share Price Today, Rubicon Research Stock News and the day\u2019s price action in the healthcare space. The data confirms a clear share price fall, but it does not establish a company-specific catalyst. What it does show is a large-cap pharmaceutical stock trading at a high valuation, with the market cap, P\/E ratio and P\/B ratio all remaining central to the Rubicon Research Share Price debate. For readers following Rubicon Research Share News on Univest, the key question is how today\u2019s decline fits into the broader stock performance picture.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-share-price-price-fall-2026-09-22\/#RUBICON_RESEARCH_RUBICON_Share_Price_Today_Price_Action_Analysis\" title=\"RUBICON RESEARCH (RUBICON) Share Price Today: Price Action Analysis\">RUBICON RESEARCH (RUBICON) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-share-price-price-fall-2026-09-22\/#RUBICON_RESEARCH_RUBICON_Fundamental_Analysis\" title=\"RUBICON RESEARCH (RUBICON) Fundamental Analysis\">RUBICON RESEARCH (RUBICON) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-share-price-price-fall-2026-09-22\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-share-price-price-fall-2026-09-22\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-share-price-price-fall-2026-09-22\/#Why_Investors_Are_Watching_Rubicon_Research\" title=\"Why Investors Are Watching Rubicon Research\">Why Investors Are Watching Rubicon Research<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-share-price-price-fall-2026-09-22\/#About_Rubicon_Research\" title=\"About Rubicon Research\">About Rubicon Research<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-share-price-price-fall-2026-09-22\/#Track_Rubicon_Research_Share_Price_on_Univest\" title=\"Track Rubicon Research Share Price on Univest\">Track Rubicon Research Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-share-price-price-fall-2026-09-22\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-share-price-price-fall-2026-09-22\/#Why_did_Rubicon_Research_Share_Price_fall_today\" title=\"Why did Rubicon Research Share Price fall today?\">Why did Rubicon Research Share Price fall today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-share-price-price-fall-2026-09-22\/#What_was_Rubicon_Research_Share_Price_Todays_close\" title=\"What was Rubicon Research Share Price Today\u2019s close?\">What was Rubicon Research Share Price Today\u2019s close?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-share-price-price-fall-2026-09-22\/#What_is_Rubicon_Researchs_market_capitalisation\" title=\"What is Rubicon Research\u2019s market capitalisation?\">What is Rubicon Research\u2019s market capitalisation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-share-price-price-fall-2026-09-22\/#How_does_Rubicon_Research_compare_on_valuation\" title=\"How does Rubicon Research compare on valuation?\">How does Rubicon Research compare on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-share-price-price-fall-2026-09-22\/#What_do_Rubicon_Researchs_ROE_and_ROCE_show\" title=\"What do Rubicon Research\u2019s ROE and ROCE show?\">What do Rubicon Research\u2019s ROE and ROCE show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-share-price-price-fall-2026-09-22\/#How_does_Rubicon_Research_compare_with_peers\" title=\"How does Rubicon Research compare with peers?\">How does Rubicon Research compare with peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-share-price-price-fall-2026-09-22\/#What_is_Rubicon_Researchs_EPS_and_book_value\" title=\"What is Rubicon Research\u2019s EPS and book value?\">What is Rubicon Research\u2019s EPS and book value?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-share-price-price-fall-2026-09-22\/#Which_sector_and_industry_does_Rubicon_Research_belong_to\" title=\"Which sector and industry does Rubicon Research belong to?\">Which sector and industry does Rubicon Research belong to?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"RUBICON_RESEARCH_RUBICON_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>RUBICON RESEARCH (RUBICON) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,692.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,731.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 39.00 (-2.25%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,730.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,730.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,684.55<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1.99 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 29,030.99 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Rubicon Research Share Price Today reflects a lower close at Rs 1,692.30 versus the previous close of Rs 1,731.30, which means the stock ended Rs 39.00 lower on the day. The session opened at Rs 1,730.25, matched the day\u2019s high at Rs 1,730.25 and slipped to a low of Rs 1,684.55. That range shows a session that began near the previous close and finished closer to the day\u2019s low. The turnover stood at Rs 1.99 crore. Since the company is classified as a Large Cap in the supplied data, today\u2019s Rubicon Research Share Price Fall is best read as a large-cap price event within the pharmaceuticals segment, rather than as a standalone story about size. The move also matters for Rubicon Research Share Price Live searches because it gives a full snapshot of current price, day change, open, high, low and traded value. On the day, the stock\u2019s decline was measured and factual, with no verified company-specific catalyst in the supplied information.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"RUBICON_RESEARCH_RUBICON_Fundamental_Analysis\"><\/span><strong>RUBICON RESEARCH (RUBICON) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 29,030.99 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">99.43x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.35x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.84%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">29.22%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 17.41<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 81.09<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.09%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The Rubicon Research Share Price sits against a market capitalisation of Rs 29,030.99 crore, a P\/E ratio of 99.43 and a P\/B ratio of 21.35. These figures place valuation at the center of Rubicon Research Fundamental Analysis and Rubicon Research Stock Analysis. The company\u2019s ROE is 27.84% and ROCE is 29.22%, both indicating strong returns on equity and capital employed relative to the valuation profile. EPS is Rs 17.41, and book value is Rs 81.09 per share, which helps frame how much accounting net worth backs each share. Dividend yield is 0.09%, which is a factual historical\/current payout measure and should be read as such. In simple terms, the Rubicon Research Share Price is supported by profitability ratios that are meaningfully above many peer benchmarks, while the valuation multiples are also well above the industry medians shown later. That mix is central to Rubicon Research Financial Results and Rubicon Research Share Price Update searches, because it puts earnings quality and valuation in the same frame. For Univest readers, the fundamentals do not explain today\u2019s decline by themselves; they provide the backdrop against which Rubicon Research Company News and Rubicon Research Latest News are being followed.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">99.43x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.62x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49.51x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.37x to 747.32x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.35x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.35x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.84%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.74%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.79%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">29.22%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.63%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.4%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 29,030.99 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 746.45 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,202.67 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Rubicon Research belongs to the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. In the supplied benchmark scope of the same industry, covering 200 companies, the company\u2019s P\/E of 99.43 is above the benchmark median of 32.62 and above the benchmark average of 49.51. Its P\/B of 21.35 is also above the benchmark median of 3.00 and benchmark average of 4.35. ROE at 27.84% is above the benchmark median of 11.74% and average of 10.79%, while ROCE at 29.22% is above the benchmark median of 13.63% and average of 13.40%. The benchmark market capitalisation median is Rs 746.45 crore and the average is Rs 14,202.67 crore, while Rubicon Research\u2019s own market cap is Rs 29,030.99 crore, which places it above both reference points. This sector and industry comparison gives Rubicon Research Share Price Today an important valuation lens: the company is larger than the median industry stock and trades on richer multiples than the benchmark range. For Rubicon Research Stock News readers, that contrast is often more important than the day\u2019s decline itself. The company\u2019s performance also needs to be read alongside the broader Healthcare sector setting, where valuation dispersion remains wide across listed pharmaceuticals names.<\/p>\n<p>Within the same industry benchmark, the company\u2019s P\/E of 99.43 sits below Divi\u2019s Laboratories at 85.60? No, the supplied numbers show Rubicon Research above Divi\u2019s Laboratories on P\/E, and also above Torrent Pharmaceuticals at 86.64, Sun Pharmaceutical Industries at 37.05, Zydus Lifesciences at 25.67, Cipla at 33.19, Aurobindo Pharma at 26.61, Lupin at 17.53, Dr. Reddy\u2019s Laboratories at 31.14 and Mankind Pharma at 49.13. On P\/B, Rubicon Research\u2019s 21.35 is higher than Sun Pharmaceutical Industries at 5.18, Divi\u2019s Laboratories at 14.18, Torrent Pharmaceuticals at 21.05, Zydus Lifesciences at 4.30, Cipla at 3.18, Aurobindo Pharma at 2.54, Lupin at 4.07, Dr. Reddy\u2019s Laboratories at 2.63 and Mankind Pharma at 5.96. Its ROE of 27.84% is above all the listed peer ROE figures supplied, and its ROCE of 29.22% is also above the listed peer ROCE figures supplied. That peer context is important for anyone scanning Rubicon Research Share Price News, because the stock\u2019s valuation is not being viewed in isolation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,40,397.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">37.05<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi-s-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Divi&#39;s Laboratories<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,48,664.42<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">85.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,82,738.23<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">86.64<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.05<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,15,012.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.67<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.3<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,10,793.75<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Among the supplied peers, Rubicon Research\u2019s market capitalisation of Rs 29,030.99 crore is below Sun Pharmaceutical Industries at Rs 4,40,397.93 crore, Divi\u2019s Laboratories at Rs 2,48,664.42 crore and Torrent Pharmaceuticals at Rs 1,82,738.23 crore, but above Zydus Lifesciences at Rs 1,15,012.19 crore and Cipla at Rs 1,10,793.75 crore. Its P\/E of 99.43 is higher than all listed peers in the supplied set, including Laurus Labs at 99.72 only narrowly above the company\u2019s own level. The P\/B ratio of 21.35 is also higher than the peer values shown, except that it is close to Torrent Pharmaceuticals at 21.05. On profitability, Rubicon Research\u2019s ROE of 27.84% and ROCE of 29.22% exceed the peer set provided. For Rubicon Research Share Price, this creates a clear contrast between strong return metrics and expensive valuation when compared with the peer basket. That contrast is central to Rubicon Research Stock Performance discussions on Univest and to anyone comparing Rubicon Research with other Pharmaceuticals &amp; Drugs names.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Rubicon_Research\"><\/span><strong>Why Investors Are Watching Rubicon Research<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Rubicon Research Share Price fell 2.25% today to Rs 1,692.30.<\/li>\n<li>The stock closed Rs 39.00 below the previous close of Rs 1,731.30.<\/li>\n<li>Market capitalisation stood at Rs 29,030.99 crore, with a Large Cap classification.<\/li>\n<li>P\/E was 99.43 and P\/B was 21.35, both above the industry benchmark shown.<\/li>\n<li>ROE of 27.84%, ROCE of 29.22%, EPS of Rs 17.41 and book value of Rs 81.09 are key numbers in the current Rubicon Research Share Price debate.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Rubicon_Research\"><\/span><strong>About Rubicon Research<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Rubicon Research operates in the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. The supplied data identifies the company within the listed pharma universe and positions it as a Large Cap stock by market-cap category. The key reported financial markers for Rubicon Research Share Price readers are market capitalisation of Rs 29,030.99 crore, EPS of Rs 17.41, book value of Rs 81.09 and dividend yield of 0.09%. In today\u2019s Rubicon Research Stock News flow, the company is being followed mainly through valuation, profitability and sector comparison rather than through any newly stated company event.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Rubicon_Research_Share_Price_on_Univest\"><\/span><strong>Track Rubicon Research Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use&nbsp;<a href=\"https:\/\/univest.in\/stocks\/rubicon\/rubicon-research-limited-share-price-today\">RUBICON RESEARCH (RUBICON) live share-price page<\/a>,<a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>,<a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top decliners and related market analysis.<\/p>\n<p>On Univest, investors can track Rubicon Research Share Price, Rubicon Research Share Price Today, Rubicon Research Share News and Rubicon Research Stock Analysis in one place. The platform also helps users review financial ratios, shareholding pattern, 52-week levels and broader market insights for better context. For Rubicon Research Share Price Live monitoring, Univest brings the company\u2019s key metrics together in a single research view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Rubicon_Research_Share_Price_fall_today\"><\/span><strong>Why did Rubicon Research Share Price fall today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Rubicon Research Share Price fell 2.25% to Rs 1,692.30. The supplied data confirms the price event, but it does not identify a company-specific catalyst or trigger for the decline. The previous close was Rs 1,731.3.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_Rubicon_Research_Share_Price_Todays_close\"><\/span><strong>What was Rubicon Research Share Price Today\u2019s close?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Rubicon Research Share Price Today closed at Rs 1,692.30, down Rs 39.00 from the previous close of Rs 1,731.30. The day\u2019s open was Rs 1,730.25. The previous close was Rs 1,731.3.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Rubicon_Researchs_market_capitalisation\"><\/span><strong>What is Rubicon Research\u2019s market capitalisation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Rubicon Research\u2019s market capitalisation is Rs 29,030.99 crore. The data classifies the company as Large Cap, which places it above the benchmark industry median market cap of Rs 746.45 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Rubicon_Research_compare_on_valuation\"><\/span><strong>How does Rubicon Research compare on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Rubicon Research Share Price sits alongside a P\/E of 99.43 and a P\/B of 21.35. Both are above the industry benchmark medians of 32.62 and 3.00 respectively, according to the supplied sector snapshot.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_Rubicon_Researchs_ROE_and_ROCE_show\"><\/span><strong>What do Rubicon Research\u2019s ROE and ROCE show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Rubicon Research reports ROE of 27.84% and ROCE of 29.22%. Both figures are above the industry benchmark median and average in the supplied Pharmaceuticals &amp; Drugs comparison set. ROE stands at 27.84%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Rubicon_Research_compare_with_peers\"><\/span><strong>How does Rubicon Research compare with peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Compared with peers such as Sun Pharmaceutical Industries, Divi\u2019s Laboratories, Torrent Pharmaceuticals and Zydus Lifesciences, Rubicon Research has higher P\/E and P\/B multiples, while its ROE and ROCE are also stronger in the supplied set.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Rubicon_Researchs_EPS_and_book_value\"><\/span><strong>What is Rubicon Research\u2019s EPS and book value?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Rubicon Research reports EPS of Rs 17.41 and book value of Rs 81.09 per share. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_sector_and_industry_does_Rubicon_Research_belong_to\"><\/span><strong>Which sector and industry does Rubicon Research belong to?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Rubicon Research belongs to the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. That sector context matters for Rubicon Research Share Price because the valuation benchmark is taken from the same industry.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>RUBICON RESEARCH Share Price falls to Rs 1,692.3. marking a 2.25% fall today. Market cap stands at Rs 29,030.99 crore.<\/p>\n","protected":false},"author":29,"featured_media":261984,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-261989","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["261984"],"rank_math_title":["Rubicon Research Share Price today: price fall and valuation"],"rank_math_description":["Rubicon Research Share Price fell 2.25% to Rs 1,692.30. Read the price action, market cap, valuation ratios, sector context and peer comparison."],"rank_math_focus_keyword":["Rubicon Research Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/RUBICON_RESEARCH_RUBICON_Share_Price_falls_225_as_stock_closes_lower_today_bearish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/261989","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=261989"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/261989\/revisions"}],"predecessor-version":[{"id":261992,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/261989\/revisions\/261992"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/261984"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=261989"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=261989"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=261989"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}